REARRANGEMENT OF THE MYELOID/LYMPHOID LEUKEMIA GENE IN THERAPY-RELATED MYELODYSPLASTIC SYNDROME (MDS) IN PATIENTS PREVIOUSLY TREATED WITH AGENTS TARGETING DNA- TOPOISOMERASE II